NASDAQ:NKTX
Nkarta, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.nkartatx.comipo date
Jul 10, 2020
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-l...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus